body composition digital phenotyping
40% More Lean Loss With Tirzepatide Vs Semaglutide
40% More Lean Loss With Tirzepatide Vs Semaglutide Patients on tirzepatide lose about 40% more lean body mass than those on semaglutide, a difference that matters for long-term health. Digital phenotyping studies show this gap emerges within weeks, prompting clinicians to weigh muscle preservation when choosing a GLP-1 therapy. Medical